Close Menu

NEW YORK (GenomeWeb) – Becton Dickinson reported today that preliminary estimates show fiscal first quarter revenues increased 35 percent, primarily due to the acquisition of C.R. Bard.

The firm reported preliminary revenues of $4.16 billion, compared to $3.08 billion in fiscal Q1 of 2018. On a currency-neutral basis, including revenues of Bard in both the current and past fiscal year, revenues increased 5 percent. Analysts had estimated first quarter revenues of $4.11 billion.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US National Institutes of Health's All of Us project awarded $4.6 million to the company Color to develop a genetic counseling resource for the program.

The Times of India reports on a pilot study that used genomic testing to determine whether patients had drug-resistant tuberculosis.

New guidelines say that more women may benefit from genetic testing for hereditary breast or ovarian cancer, according to the Los Angeles Times.

In Cell this week: small proteins identified among human microbiome, role for tumor microbes in pancreatic cancer survival, and more.